Literature DB >> 20963594

Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells.

Rui Zeng1, Yu-cheng Chen, Zhi Zeng, Wei-qiang Liu, Xiao-fei Jiang, Rui Liu, Ou Qiang, Xian Li.   

Abstract

The purpose of this study was to determine the mechanism of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase (mini-TyrRS/mini-TrpRS) on ischemic angiogenesis in rats with acute myocardial infarction and proliferation, migration, potential signaling pathways of rat coronary venular endothelial cells (RCVECs). The effects of mini-TyrRS/mini-TrpRS on RCVECs proliferation were evaluated using the MTT colorimetric assay. Cell migration was assayed using a modified Boyden chamber technique. The potential involvement of Erk and PI3K signaling pathways was explored using selective chemical inhibitor or Western-blot analysis. Left coronary artery ligation was used to establish the model of acute myocardial infarction in rats (Sprague-Dawley male rats, 200-250 g, 2-3 months old), 20 μl of mini-TyrRS, mini-TrpRS, or PBS (vehicle) was injected subcutaneously every 12 h. The rats were randomly divided into four experimental groups: sham operated group; coronary artery ligation (CAL); CAL + mini-TyrRS (20 μl, twice daily, 600 μg kg(-1) day(-1)); and CAL + mini-TrpRS (20 μl, twice daily, 600 μg kg(-1) day(-1)). The experiment was carried out at four time points on the 3rd, 7th, 14th, and 28th day after ligation. To determine whether mini-TyrRS/mini-TrpRS affected the angiogenesis activity of rats with myocardial infarction, we measured the myocardial infarction size by TTC staining, and microvessel density (MVD) was determined by CD34 staining. The results show that proliferation and migration in RCVECs could be promoted by mini-TyrRS at concentrations of 1-100 μg/ml, and inhibited by mini-TrpRS. Phospho-PI3-kinase and Erk expression increased significantly when mini-TyrRS was added, but could be attenuated by mini-TrpRS. Compared to the CAL group, the myocardial infarction size of the mini-TyrRS group at the 3rd, 7th, 14th, and 28th day were decreased, while mini-TrpRS increased, but only in days 14 and 28 was there a significant difference. Except that, the microvessel density of RCVECs was promoted in mini-TyrRS group but inhibited in the mini-TrpRS group. These results indicated that angiogenesis could be either stimulated by mini-TyrRS or inhibited by mini-TrpRS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963594     DOI: 10.1007/s00380-010-0032-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Authors:  Atsushi Otani; Bonnie M Slike; Michael I Dorrell; John Hood; Karen Kinder; Karla L Ewalt; David Cheresh; Paul Schimmel; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

2.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase.

Authors:  K Wakasugi; P Schimmel
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

Review 3.  Aminoacyl-tRNA synthetase complexes: beyond translation.

Authors:  Sang Won Lee; Byeong Hoon Cho; Sang Gyu Park; Sunghoon Kim
Journal:  J Cell Sci       Date:  2004-08-01       Impact factor: 5.285

4.  Prognostic value of coronary flow reserve and aortic distensibility indices in patients with suspected coronary artery disease.

Authors:  Attila Nemes; Tamás Forster; Marcel L Geleijnse; Osama I I Soliman; Folkert J Ten Cate; Miklós Csanády
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

5.  Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP.

Authors:  Phoebe Lin; Emily J Welch; Xiao-Pei Gao; Asrar B Malik; Richard D Ye
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

6.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

7.  Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia.

Authors:  P R Vale; D W Losordo; C E Milliken; M C McDonald; L M Gravelin; C M Curry; D D Esakof; M Maysky; J F Symes; J M Isner
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

8.  Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.

Authors:  Olivier Gach; Olivier Louis; Jean Paul Chapelle; Sophie Vanbelle; Luc A Pierard; Victor Legrand
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

9.  Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population.

Authors:  Patrícia Matos Biselli; Alexandre Rodrigues Guerzoni; Moacir Fernandes de Godoy; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

10.  Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines.

Authors:  J Fleckner; P M Martensen; A B Tolstrup; N O Kjeldgaard; J Justesen
Journal:  Cytokine       Date:  1995-01       Impact factor: 3.861

View more
  8 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  VEGF, not VEGFR2, is associated with the angiogenesis effect of mini-TyrRS/mini-TrpRS in human umbilical vein endothelial cells in hypoxia.

Authors:  Rui Zeng; Xiao-Fei Jiang; Yu-Cheng Chen; Yuan-Ning Xu; Song-Hong Ma; Zhi Zeng; Rui Liu; Ou Qiang; Xian Li
Journal:  Cytotechnology       Date:  2013-07-30       Impact factor: 2.058

3.  Inhibition of mini-TyrRS-induced angiogenesis response in endothelial cells by VE-cadherin-dependent mini-TrpRS.

Authors:  Rui Zeng; Yu-cheng Chen; Zhi Zeng; Xiao-xia Liu; Rui Liu; Ou Qiang; Xian Li
Journal:  Heart Vessels       Date:  2011-03-26       Impact factor: 2.037

4.  Matrix metalloproteinases inactivate the proinflammatory functions of secreted moonlighting tryptophanyl-tRNA synthetase.

Authors:  Parker G Jobin; Nestor Solis; Yoan Machado; Peter A Bell; Nam Hoon Kwon; Sunghoon Kim; Christopher M Overall; Georgina S Butler
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

5.  Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart.

Authors:  Jun-jie Yang; Zhi-qiang Liu; Jin-ming Zhang; Hai-bin Wang; Shun-yin Hu; Jian-feng Liu; Chang-yong Wang; Yun-dai Chen
Journal:  Heart Vessels       Date:  2012-09-01       Impact factor: 2.037

6.  Natural aminoacyl tRNA synthetase fragment enhances cardiac function after myocardial infarction.

Authors:  Margaret E McCormick; Mauricio Rojas; Tyler Moser-Katz; Ellie Tzima; John S Reader
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

7.  IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.

Authors:  Richard Metz; Sonja Rust; James B Duhadaway; Mario R Mautino; David H Munn; Nicholas N Vahanian; Charles J Link; George C Prendergast
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

8.  New Candidates for Biomarkers and Drug Targets of Ischemic Stroke-A First Dynamic LC-MS Human Serum Proteomic Study.

Authors:  Aleksandra Turek-Jakubowska; Janusz Dębski; Maciej Jakubowski; Ewa Szahidewicz-Krupska; Jakub Gawryś; Karolina Gawryś; Agnieszka Janus; Małgorzata Trocha; Adrian Doroszko
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.